DIA
Drug Information Association Logo

Advanced Search

MM-DD-YYYY

Add Filter

    Advanced Search

    Find Meetings & Training 

    Name Start Date Credits Format Region Location
    How to Prepare for a Safety Inspection Jun 1, 2015 IACET Online Instruction Global Online
    Clinical Investigator: Module 2 - Conducting the Study Jun 2, 2015 ACPE, CME Online Instruction North America Online
    Clinical Investigator: Module 1 - Study Preparation and Initiation Jun 2, 2015 ACPE, CME Online Instruction North America Online
    Informed Consent Jun 2, 2015 ACPE Online Instruction North America Online
    Crisis Management Jun 2, 2015 ACPE, IACET Online Instruction North America Online
    Database Management Jun 2, 2015 ACPE, IACET Online Instruction North America Online
    Literature Evaluation Jun 2, 2015 ACPE, IACET Online Instruction North America Online
    Literature Searching Jun 2, 2015 ACPE, IACET Online Instruction North America Online
    Medical Inquiries Jun 2, 2015 ACPE, IACET Online Instruction North America Online
    Medical Writing Jun 2, 2015 IACET Online Instruction North America Online
    Product Labeling Jun 2, 2015 ACPE, IACET Online Instruction North America Online
    Regulatory Issues Jun 2, 2015 ACPE, IACET Online Instruction North America Online
    Statistics for Medical Communications Professionals Jun 2, 2015 ACPE, IACET Online Instruction North America Online
    Expert Reactor Panel: IOM Report on Sharing Clinical Trial Data Jun 2, 2015 Online Instruction Global Online
    Novel Data Sources: The Positive Impact of Social Media and Online Networks for Engaging with Patients Jun 2, 2015 Online Instruction Global Online
    FDA’s Evolving Position on the Brief Summary and Adequate Directions for Use Guidance Jun 2, 2015 Online Instruction Global Online
    Target Product Profile – Strategies to Optimize Drug Development, Product Labeling, and Commercialization Jun 2, 2015 Online Instruction Global Online
    GVP Module IX Compliant Signal Management Systems in Pharmacovigilance: A Tale of Two Experiences Jun 2, 2015 Online Instruction Global Online
    Complimentary Webinar - Using Revolutionary Machine Learning to Find the Most Relevant Content to Drive Informed Decisions in Regulatory Intelligence Jun 2, 2015 Online Instruction Global Online
    The Role of the Clinical Data Manager Jun 2, 2015 Online Instruction Global Online
    Implementation of the FDASIA Patient Provisions Jun 2, 2015 Online Instruction Global Online
    Complimentary: Regulatory and Real World Evidence Challenges of Rare Diseases and Orphan Drugs Jun 2, 2015 Online Instruction Global Online
    FDA’s Role in Advancing the Science of Pharmacovigilance: Tools, Methods, and Pilot Programs Under Evaluation for the Analysis of Safety Signals Jun 2, 2015 Online Instruction Global Online
    Variations in the European Union: CMC/Quality Changes Jun 2, 2015 Online Instruction Global Online
    Proarrhythmia Jun 2, 2015 Online Instruction Global Online
    Facets of Drug-Induced Kidney Injury and Regulatory Perspective Jun 2, 2015 Online Instruction Global Online
    Impact on Drug Development of Novel Translational Safety Biomarkers for Improved Detection of Drug-Induced Acute Kidney Injury Jun 2, 2015 Online Instruction Global Online
    Pharmacovigilance and Risk Management: Patient Perspective Jun 2, 2015 Online Instruction Global Online
    Drug Safety Regulatory Requirements Jun 2, 2015 ACPE, IACET Online Instruction Global Online
    Premarketing Clinical Trial Safety Jun 2, 2015 ACPE, IACET Online Instruction Global Online
    Postmarketing Safety Management Jun 2, 2015 ACPE, IACET Online Instruction Global Online
    Basics of Signal Detection and Pharmacoepidemiology Jun 2, 2015 ACPE, IACET Online Instruction Global Online
    Safety Audits and Inspections Jun 2, 2015 ACPE, IACET Online Instruction Global Online
    Five-Part Series on Fundamentals of Clinical Pharmacology for Drug Development - Part 1: Fundamentals of Clinical Pharmacology: Pharmacokinetics Jun 2, 2015 Online Instruction Global Online
    Five-Part Series on Fundamentals of Clinical Pharmacology for Drug Development - Part 2: Fundamentals of Clinical Pharmacology: Pharmacodynamics Jun 2, 2015 Online Instruction Global Online
    Pharmacovigilance and Global Harmonization Updates Jun 2, 2015 Online Instruction Global Online
    Five-Part Series on Fundamentals of Clinical Pharmacology For Drug Development - Part 3: Principles of Modeling and Simulation Jun 2, 2015 Online Instruction Global Online
    Five-Part Series on Fundamentals of Clinical Pharmacology for Drug Development - Part 4: Determining the Safe First Human Dose Jun 2, 2015 Online Instruction Global Online
    Five-Part Series on Fundamentals of Clinical Pharmacology for Drug Development - Part 5: Assessment of QT Prolongation Jun 2, 2015 Online Instruction Global Online
    Negotiation and Influence Jun 2, 2015 Online Instruction Global Online
    Introduction to Drug Safety Jun 2, 2015 ACPE, IACET Online Instruction Global Online
    How to Prepare for a Safety Inspection Jun 2, 2015 Online Instruction Global Online
    Implementation and Status of Periodic Benefit-Risk Evaluation Reporting (PBRER) in Canada Jun 2, 2015 Online Instruction Global Online
    Clinical Statistics for Nonstatisticians Jun 2, 2015 Online Instruction Global Online
    Advanced Clinical Statistics for Nonstatisticians Jun 2, 2015 Online Instruction Global Online
    Development of a Clinical Study Report Jun 2, 2015 Online Instruction Global Online
    Oversight of Clinical Monitoring: Trends and Strategies Jun 2, 2015 Online Instruction Global Online
    Art of Writing a Clinical Overview Jun 2, 2015 Online Instruction Global Online
    Seven-Part Series on Pediatric Drug Development - Part 6: Preclinical Toxicology & Safety Jun 2, 2015 Online Instruction Global Online
    Complimentary - Need to Reinvent the Clinical Trial? Innovate, Collaborate & Integrate Jun 2, 2015 Online Instruction Global Online
    Complimentary Webinar - How to Cut Clinical Trial Timelines in Half Jun 2, 2015 Online Instruction Global Online
    Disruptive Innovation in Medical Information Jun 2, 2015 Online Instruction Global Online
    A Tour of FDA Jun 2, 2015 Online Instruction Global Online
    A Tour of Health Canada Jun 2, 2015 Online Instruction Global Online
    A Tour of Health Europe Jun 2, 2015 Online Instruction Global Online
    Aspects of Regulatory History Jun 2, 2015 Online Instruction Global Online
    Bioresearch Monitoring Program (BIMO): Introduction Jun 2, 2015 Online Instruction Global Online
    The Clinical Development Process: Investigational Product, Plan, and Data Management Jun 2, 2015 Online Instruction Global Online
    Ethical Review Boards Jun 2, 2015 Online Instruction Global Online
    Ethics as the Foundation to Clinical Research Jun 2, 2015 Online Instruction Global Online
    Awareness of FDA Inspections for Pharmaceutical Manufacturers Jun 2, 2015 Online Instruction Global Online
    Biotechnology: An Overview of Compliance Considerations Jun 2, 2015 Online Instruction Global Online
    Change Control Jun 2, 2015 Online Instruction Global Online
    Clinical Trial Audits and Consequences of Non-Compliance Jun 2, 2015 Online Instruction Global Online
    Computerized Systems Inspections in the Medical Device Industry Jun 2, 2015 Online Instruction Global Online
    European Union Clinical Trials Directive Jun 2, 2015 Online Instruction Global Online
    GMP Principals of SOPs Jun 2, 2015 Online Instruction Global Online
    GMP Updates - Enforcement Changes at the New FDA Jun 2, 2015 Online Instruction Global Online
    GMPs for API Bulk Manufacturers Jun 2, 2015 Online Instruction Global Online
    Good Clinical Practices (GCPs) for New Product Investigations Jun 2, 2015 Online Instruction Global Online
    Good Laboratory Practices (GLPs) Jun 2, 2015 Online Instruction Global Online
    GxPs Jun 2, 2015 Online Instruction Global Online
    HIPAA - The Impact on Clinical Research Jun 2, 2015 Online Instruction Global Online
    Introduction to GMPs Jun 2, 2015 Online Instruction Global Online
    Investigational Product Development Jun 2, 2015 Online Instruction Global Online
    ISO 14155: Obligations of Sponsors and Monitors for Medical Device Trials Jun 2, 2015 Online Instruction Global Online
    Key Concepts of Process Validation Jun 2, 2015 Online Instruction Global Online
    Laboratory Specimens for Clinical Research Jun 2, 2015 Online Instruction Global Online
    Medical Device Safety Reporting Jun 2, 2015 Online Instruction Global Online
    Orientation to GMP Compliance Jun 2, 2015 Online Instruction Global Online
    Overview of the Clinical Research Process Jun 2, 2015 Online Instruction Global Online
    Part 11: Electronic Records and Signatures - Application Jun 2, 2015 Online Instruction Global Online
    Part 11: Electronic Records; Electronic Signatures Jun 2, 2015 Online Instruction Global Online
    Principles of Good Documentation Jun 2, 2015 Online Instruction Global Online
    Protection of Human Subjects in Clinical Trials Jun 2, 2015 Online Instruction Global Online
    Selecting and Managing Clinical Contract Research Organizations (CROs) Jun 2, 2015 Online Instruction Global Online
    Understanding Post-Approval Changes Jun 2, 2015 Online Instruction Global Online
    Computerized Systems Inspections in the Pharmaceutical Industry Jun 2, 2015 Online Instruction Global Online
    Basics of the PhRMA Code Jun 2, 2015 Online Instruction Global Online
    Basics of AdvaMed Code Jun 2, 2015 Online Instruction Global Online
    Eucomed Guidelines on Interactions with Healthcare Professionals Jun 2, 2015 Online Instruction Global Online
    Introduction to Medical Device Health Care Compliance Jun 2, 2015 Online Instruction Global Online
    Foreign Corrupt Practices Act Jun 2, 2015 Online Instruction Global Online
    Global Anti-bribery Jun 2, 2015 Online Instruction Global Online
    Variations to Marketing Authorisation in Europe Jun 2, 2015 Online Instruction Global Online
    Registration of Monoclonal Antibodies Jun 2, 2015 Online Instruction Global Online
    How to Gain Approval to Market a Generic Medicinal Product in the USA Jun 2, 2015 Online Instruction Global Online
    Pharmacokinetics and Pharmacodynamics in Drug Registration Jun 2, 2015 Online Instruction Global Online
    Implementing Risk-Based Monitoring: Practical Approaches Jun 2, 2015 Online Instruction Global Online
    Complimentary - Innovative Strategies for Developing Safer Cancer Therapies Jun 2, 2015 Online Instruction Global Online
    eRegulatory and Intelligence Virtual Conference Archive Jun 2, 2015 Online Instruction Global Online
    Complimentary Archive Webinar - Next Generation Feasibility: Better Planning Through Simulation Jun 2, 2015 Online Instruction Global Online
    A New Era of Open Dialog and Communication: The Impact of FDASIA, PDUFA V, and Critical Path Innovation Meetings Jun 2, 2015 Online Instruction Global Online
    Planning and Managing Your Projects Jun 2, 2015 Online Instruction Global Online
    Team Building and Development Jun 2, 2015 Online Instruction Global Online
    Preparing a Clinical Trial Budget Jun 2, 2015 Online Instruction Global Online
    Postmarketing Requirements: The Legal Framework, How They Are Issued, Sponsor Obligations, and Challenges to Overcome Jun 2, 2015 Online Instruction Global Online
    Introduction to the European Union Institutions and Regulatory Authority Jun 2, 2015 Online Instruction Global Online
    Introduction to US Institutions and Regulatory Authority (FDA) Jun 2, 2015 Online Instruction Global Online
    Introduction to Japanese Institutions and Regulatory Authorities Jun 2, 2015 Online Instruction Global Online
    Overview of the CTD and eCTD Jun 2, 2015 Online Instruction Global Online
    Introduction to the International Conference on Harmonisation (ICH) Jun 2, 2015 Online Instruction Global Online
    The Regulatory Development of a Drug Jun 2, 2015 Online Instruction Global Online
    Basics of Clinical Trials Jun 2, 2015 Online Instruction Global Online
    How to Register Medicinal Products through the Centralized Procedure Jun 2, 2015 Online Instruction Global Online
    How to Register Medicinal Products through the Mutual Recognition Procedure Jun 2, 2015 Online Instruction Global Online
    How to Maintain Marketing Approvals in Europe for Centrally Authorised Products Jun 2, 2015 Online Instruction Global Online
    How to Register a New Drug in the USA Jun 2, 2015 Online Instruction Global Online
    How to Register Medicinal Products through the Decentralized Procedure Jun 2, 2015 Online Instruction Global Online
    Access to Unapproved Drugs through Compassionate Use Jun 2, 2015 Online Instruction Global Online
    Regulatory Requirements for the Conduct of Clinical Trials in Europe Jun 2, 2015 Online Instruction Global Online
    Orphan Drugs in the USA, European Union, and Japan Jun 2, 2015 Online Instruction Global Online
    Regulatory Requirements for the Submission of Investigational New Drug Applications in the USA (INDs) Jun 2, 2015 Online Instruction Global Online
    Meeting Opportunities with Regulatory Agencies Jun 2, 2015 Online Instruction Global Online
    Complementary - How New Electronic Trial Master File (eTMF) Data Standards Can Enhance Clinical Trial Efficiency and Quality Jun 2, 2015 Online Instruction Global Online
    Complimentary - Regulatory Solutions in the Cloud - 10 Questions You Can't Afford NOT to Ask Jun 2, 2015 Online Instruction Global Online
    Clinical Trials Transparency 3-Part Series: Moving the Debate Forward - Realizing the Benefits of Providing Greater Access to Clinical Trial Data: Part 1 - Paving the Way for Greater Access To Data Jun 2, 2015 Online Instruction Global Online
    Clinical Trials Transparency 3-Part Series: Moving the Debate Forward-Realizing the Benefits of Providing Greater Access to Clinical Trial Data: Part 2-Connecting the Research Community: Data Sharing–Perspectives from Academia and Patient Advocacy Groups Jun 2, 2015 Online Instruction Global Online
    Complimentary - From the Clinic to the CFO: Adaptive Trials and Financial Decision-Making Jun 2, 2015 Online Instruction Global Online
    Adverse Event Reporting Requirements: IND and Postmarketing Jun 2, 2015 Online Instruction Global Online
    Complimentary - The Affiliate Challenge – How to Improve Compliance and Efficiency when Working with Regional Affiliates Jun 2, 2015 Online Instruction Global Online
    Seven-Part Series on Pediatric Drug Development - Part 1: Overall Challenge: The Vision of Better Medicines for Children Jun 2, 2015 Online Instruction Global Online
    Seven-Part Series on Pediatric Drug Development - Part 3: Regulatory Framework EU Jun 2, 2015 Online Instruction Global Online
    Seven-Part Pediatric Drug Development Webinar Series - Part 4: Dosing in Children Jun 2, 2015 Online Instruction Global Online
    Seven-Part Series on Pediatric Drug Development - Part 2: Regulatory Framework US Overview Jun 2, 2015 Online Instruction Global Online
    Seven-Part Series on Pediatric Drug Development - Part 5: Technical Development: Pediatric Formulations Jun 2, 2015 Online Instruction Global Online
    Basics of the NDA Phase Jun 2, 2015 Online Instruction Global Online
    Regulatory Aspects of Prescription Drug/Biologics Advertising and Promotional Labeling Jun 2, 2015 Online Instruction Global Online
    Basics of the IND Phase Jun 2, 2015 Online Instruction Global Online
    Seven-Part Series on Pediatric Drug Development - Part 7: Operational Challenges of Pediatric Clinical Trials Jun 2, 2015 Online Instruction Global Online
    Supplements and Other Changes to an Approved Application Jun 2, 2015 Online Instruction Global Online
    Clinical Trials Transparency 3 Part Webinar Series - Part 3: Understanding the Legislation Landscape: Regulatory Updates from the FDA, EMA and Health Canada Jun 2, 2015 Online Instruction Global Online
    FDA’s Role in Advancing the Science of Pharmacovigilance: Tools, Methods, and Pilot Programs Under Evaluation for the Analysis of Safety Signals Jun 4, 2015 ACPE, IACET Online Instruction Global Online
    #20: The Sunshine Act: Understanding the Essentials of Compliance Jun 14, 2015 CME, IACET, RN In-Person Instruction North America Washington, DC, United States
    #21: Leadership: How to Organize and Lead People in a Work Group Jun 14, 2015 IACET, PMI In-Person Instruction North America Washington, DC, United States
    #22: Successful Drug Development: Best Practices for Clinical Trial Design, Agency Interactions, and Regulatory Document Writing Jun 14, 2015 IACET In-Person Instruction North America Washington, DC, United States
    #23: How to Prepare for an FDA Inspection Jun 14, 2015 CME, IACET, RN In-Person Instruction North America Washington, DC, United States
    #25: Signal Detection: Identifying and Managing Safety Signals Jun 14, 2015 ACPE, CME, IACET, RN In-Person Instruction North America Washington, DC, United States
    DIA 2015 51st Annual Meeting: Develop. Innovate. Advance. Jun 14, 2015 ACPE, CME, IACET, RN, PMI Meetings North America Washington, DC, United States
    #40: Analysis of Safety Data from Clinical Trials Jun 14, 2015 ACPE, CME, IACET, RN In-Person Instruction North America Washington, DC, United States
    #41: Quality Oversight of CROs-Clinical Vendors Jun 14, 2015 IACET In-Person Instruction North America Washington, DC, United States
    #42: Fundamentals of ANDA Submissions and FDA Expectations Under GDUFA Jun 14, 2015 CME, IACET, RN In-Person Instruction North America Washington, DC, United States
    #43: Clinical Statistics for Nonstatisticians Jun 14, 2015 ACPE, CME, IACET, RN In-Person Instruction North America Washington, DC, United States
    #44: Risk Management and Safety Communication Strategies Jun 14, 2015 ACPE, CME, IACET, RN In-Person Instruction North America Washington, DC, United States
    #45: The Good Pharmacovigilance Practices in the EU: Global Applications Jun 14, 2015 CME, IACET, RN In-Person Instruction North America Washington, DC, United States
    #30: Japan Regulatory Environment: Overview of the Organization, Processes, Systems, and Changes Affecting Pharmaceutical Development Jun 14, 2015 IACET In-Person Instruction North America Washington, DC, United States
    #31: Preparing for a US FDA Advisory Committee Meeting Jun 14, 2015 IACET In-Person Instruction North America Washington, DC, United States
    #32: Influencing Culture, Avoiding Bureaucracy, and Encouraging Innovation Jun 14, 2015 IACET In-Person Instruction North America Washington, DC, United States
    #34: Preparation of Risk Evaluation and Mitigation Strategies Assessment Reports Jun 14, 2015 ACPE, CME, IACET, RN In-Person Instruction North America Washington, DC, United States
    #35: Ethical Issues in Clinical Trials Jun 14, 2015 CME, IACET, RN In-Person Instruction North America Washington, DC, United States
    A New Era of Open Dialog and Communication: The Impact of FDASIA, PDUFA V, and Critical Path Innovation Meetings Jun 24, 2015 Online Instruction Global Online
    Adverse Event Reporting Requirements: IND and Post-marketing Jul 13, 2015 IACET Online Instruction Global Online
    Interactions with the FDA during IND/NDA Phases Jul 16, 2015 IACET Online Instruction Global Online
    Global Regulatory Strategy and Drug Development in Asia-Pacific, Latin America, and Other Emerging Markets Aug 3, 2015 In-Person Instruction North America Washington, DC, United States
    Development of a Clinical Study Report Aug 10, 2015 IACET In-Person Instruction North America Boston, MA, United States
    Regulatory Affairs: The IND, NDA, and Postmarketing Aug 10, 2015 IACET In-Person Instruction North America Boston, MA, United States
    Pragmatic Approaches to Drug Safety Across the Premarketing and Postmarketing Continuum Aug 10, 2015 ACPE, IACET In-Person Instruction North America Boston, MA, United States
    European Regulatory Affairs: Keeping Your Finger on the Pulse of Marketing Authorizations Aug 11, 2015 In-Person Instruction North America Boston, MA, United States
    Clinical Project Management Aug 24, 2015 IACET, PMI In-Person Instruction North America Washington, DC, United States
    New Drug Product Development and Life Cycle Management Aug 26, 2015 IACET, PMI In-Person Instruction North America Washington, DC, United States
    Overview of Drug Development in Japan Sep 2, 2015 Online Instruction Global Online
    DIA/FDA Oligonucleotide-Based Therapeutic Conference 2015 Sep 9, 2015 Meetings North America Washington, DC, United States
    Patient Engagement in Benefit-Risk Assessment throughout the Life Cycle of Medical Products Sep 17, 2015 Meetings North America North Bethesda, MD, United States
    Clinical Trial Disclosure & Data Transparency – The Expanding Global Environment Sep 17, 2015 Meetings North America Bethesda, MD, United States
    Adaptive Design in Clinical Trials: When and How to Apply Sep 21, 2015 IACET In-Person Instruction North America Washington, DC, United States
    Drug and Device Combination Products 2015: Navigating Regulation, Enhancing Collaboration, and Accelerating Development Sep 28, 2015 Meetings North America Bethesda, MD, United States
    Pragmatic Approaches to Drug Safety Across the Premarketing and Postmarketing Continuum Sep 28, 2015 ACPE, IACET In-Person Instruction North America Toronto, ON, Canada
    Clinical Statistics for Nonstatisticians Sep 28, 2015 ACPE, IACET In-Person Instruction North America Washington, DC, United States
    Companion Diagnostics Sep 30, 2015 Meetings North America Bethesda, MD, United States
    Central Audit Methods for Site Image Interpretation in Clinical Trials Oct 1, 2015 Meetings North America North Bethesda, MD, United States
    Introduction to Signal Detection and Data Mining Oct 5, 2015 IACET Online Instruction Global Online
    Achieving Meaningful Regulatory and Clinical Outcomes for Patients: Strategies in Rare Disease Therapy Development Oct 7, 2015 Meetings North America Bethesda, MD, United States
    Tutorial 1: Achieving Biosimilarity Through Matching of Critical Quality Attributes to Reference Product’s Oct 18, 2015 In-Person Instruction North America Bethesda, MD, United States
    Biosimilars Oct 19, 2015 Meetings North America Bethesda, MD, United States
    Risk Management and Safety Communication Oct 26, 2015 ACPE, IACET In-Person Instruction North America Washington, DC, United States
    DIA Annual Canadian Meeting 2015 Oct 27, 2015 Meetings North America Ottawa, ON, Canada
    Postmarketing Drug Safety & Pharmacovigilance Nov 9, 2015 ACPE, IACET In-Person Instruction North America Philadelphia, PA, United States
    Regulatory Affairs: The IND, NDA, and Postmarketing Nov 9, 2015 IACET In-Person Instruction North America Philadelphia, PA, United States
    Navigating Chemistry, Manufacturing and Controls Through the Drug Development Process Nov 9, 2015 IACET In-Person Instruction North America Philadelphia, PA, United States
    Advanced Clinical Statistics for NonStatisticians Nov 11, 2015 ACPE, IACET In-Person Instruction North America Philadelphia, PA, United States
    Pharmacovigilance and Risk Management Strategies 2016 Jan 25, 2016 Meetings North America
    Medical and Scientific Communications 2016 Annual Forum Mar 21, 2016 Meetings North America Kissimmee, FL, United States
    DIA 2016 52nd Annual Meeting Jun 26, 2016 Meetings North America Philadelphia, PA, United States